Biovitrum, BioFocus drug discovery deal

Metabolic and cancer play Biovitrum (Stockholm, Sweden) will supply G protein-coupled receptors (GPCRs) to BioFocus (LSE:BIO) under a joint drug discovery deal. BIO will use its thematic analysis comp...